Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

SHE:002422 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	6,327	3,974	4,675	4,729	2,920	2,772
Short-Term Investments	-	555.65	579.39	-	-	-
Trading Asset Securities	1,509	1,921	1,691	448.11	359.53	265.42
Cash & Short-Term Investments	7,835	6,451	6,946	5,177	3,279	3,037
Cash Growth	10.61%	-7.13%	34.17%	57.88%	7.96%	34.79%
Accounts Receivable	5,834	6,098	6,120	7,198	6,463	7,432
Other Receivables	109.38	126.17	162.49	256.3	221.92	117.57
Receivables	5,944	6,224	6,283	7,454	6,685	7,549
Inventory	3,463	3,801	3,840	3,214	3,363	3,468
Other Current Assets	3,263	1,460	1,222	804.22	681.4	645.3
Total Current Assets	20,505	17,936	18,290	16,649	14,009	14,700
Property, Plant & Equipment	12,947	13,012	12,086	11,331	11,614	11,987
Long-Term Investments	4,583	4,281	3,992	3,809	3,409	2,751
Goodwill	98.66	98.66	98.66	98.66	98.66	158.45
Other Intangible Assets	1,207	1,223	1,277	1,201	1,063	987.8
Long-Term Deferred Tax Assets	419.49	423.03	342.57	618.21	581.57	552.18
Long-Term Deferred Charges	63.93	83.06	75.72	233.81	365.28	516.12
Other Long-Term Assets	280.27	260.11	293.17	264.34	400.05	330.62
Total Assets	40,104	37,316	36,455	34,206	31,540	31,983
Accounts Payable	2,282	2,574	2,539	2,244	2,156	1,861
Accrued Expenses	479.2	2,259	2,028	1,973	1,610	2,525
Short-Term Debt	2,940	2,457	3,458	4,499	5,183	5,067
Current Portion of Long-Term Debt	453.77	808.4	746.86	2,012	3,199	2,208
Current Portion of Leases	-	62.56	40.53	17.31	11.57	-
Current Income Taxes Payable	259.75	140.11	162.74	108.18	119.48	92.6
Current Unearned Revenue	392.42	645.45	839.83	360.36	264.69	187.88
Other Current Liabilities	3,351	190.71	177.87	889.3	864.55	316.52
Total Current Liabilities	10,158	9,138	9,993	12,104	13,408	12,258
Long-Term Debt	193.55	342	2,649	4,704	3,506	5,100
Long-Term Leases	534.12	537.46	245.23	51.74	16.18	-
Long-Term Unearned Revenue	318.78	294.65	288.21	208.88	225.73	362.07
Long-Term Deferred Tax Liabilities	274.39	266.09	264.1	265.83	254.32	260.55
Other Long-Term Liabilities	2.82	-	0.08	-	-	-
Total Liabilities	11,481	10,578	13,439	17,335	17,410	17,980
Common Stock	1,598	1,601	1,499	1,422	1,425	1,439
Additional Paid-In Capital	8,742	7,732	6,144	3,673	3,581	3,889
Retained Earnings	13,422	13,222	11,973	10,416	9,328	8,675
Treasury Stock	-131.7	-191.83	-215.14	-237.08	-399.98	-499.88
Comprehensive Income & Other	77.22	115.84	272.07	459.82	-77.49	-3.51
Total Common Equity	23,708	22,480	19,672	15,734	13,857	13,499
Minority Interest	4,915	4,259	3,343	1,137	272.62	503.99
Shareholders' Equity	28,623	26,738	23,016	16,871	14,129	14,003
Total Liabilities & Equity	40,104	37,316	36,455	34,206	31,540	31,983
Total Debt	4,121	4,207	7,139	11,285	11,916	12,375
Net Cash (Debt)	3,715	2,243	-193.52	-6,108	-8,637	-9,337
Net Cash Per Share	2.32	1.42	-0.13	-4.12	-6.11	-6.53
Filing Date Shares Outstanding	1,626	1,591	1,488	1,412	1,406	1,430
Total Common Shares Outstanding	1,626	1,591	1,488	1,412	1,406	1,430
Working Capital	10,347	8,798	8,297	4,545	600.44	2,442
Book Value Per Share	14.58	14.13	13.22	11.15	9.85	9.44
Tangible Book Value	22,402	21,158	18,297	14,434	12,695	12,353
Tangible Book Value Per Share	13.78	13.30	12.29	10.23	9.03	8.64
Buildings	-	7,464	6,557	6,160	6,057	5,932
Machinery	-	13,101	11,592	11,348	11,078	10,793
Construction In Progress	-	1,204	2,045	1,126	922.73	840.67

Source: S&P Global Market Intelligence. Standard template. Financial Sources.